Literature DB >> 32971468

Innate lymphoid cells: from helper to killer.

Lisette Krabbendam1, Jochem H Bernink1, Hergen Spits2.   

Abstract

Five subsets of ILCs are extensively described, Lymphoid Tissue inducer (LTi) cells, cytotoxic NK cells and non-cytotoxic helper ILC1s, ILC2s and ILC3s. So far, the main focus has been on the potent cytokine production by helper ILCs and their plastic nature that allows them to switch function and phenotype upon environmental changes. Recent advances in the field indicate the presence of cytotoxic helper ILCs that are distinct from conventional NK cells. In humans, these cytotoxic ILCs can develop from conventional helper ILCs whereas in mice this remains to be elucidated. In this review we discuss the identification, development and function of cytotoxic helper ILCs subsets in humans and mice.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32971468     DOI: 10.1016/j.coi.2020.08.007

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  13 in total

1.  Intraepithelial ILC1-like cells: Front-line fighters in human head and neck squamous cell carcinoma.

Authors:  Marina Cella; Michelle L Robinette
Journal:  Proc Natl Acad Sci U S A       Date:  2021-08-17       Impact factor: 11.205

2.  Hobit confers tissue-dependent programs to type 1 innate lymphoid cells.

Authors:  Kentaro Yomogida; Tarin M Bigley; Tihana Trsan; Susan Gilfillan; Marina Cella; Wayne M Yokoyama; Takeshi Egawa; Marco Colonna
Journal:  Proc Natl Acad Sci U S A       Date:  2021-12-14       Impact factor: 12.779

3.  Cytotoxic granzyme C-expressing ILC1s contribute to antitumor immunity and neonatal autoimmunity.

Authors:  Briana G Nixon; Chun Chou; Chirag Krishna; Saïda Dadi; Adam O Michel; Andrew E Cornish; Emily R Kansler; Mytrang H Do; Xinxin Wang; Kristelle J Capistrano; Alexander Y Rudensky; Christina S Leslie; Ming O Li
Journal:  Sci Immunol       Date:  2022-04-08

4.  Effector differentiation downstream of lineage commitment in ILC1s is driven by Hobit across tissues.

Authors:  Christin Friedrich; Renske L R E Taggenbrock; Rémi Doucet-Ladevèze; Gosia Golda; Rebekka Moenius; Panagiota Arampatzi; Natasja A M Kragten; Katharina Kreymborg; Mercedes Gomez de Agüero; Wolfgang Kastenmüller; Antoine-Emmanuel Saliba; Dominic Grün; Klaas P J M van Gisbergen; Georg Gasteiger
Journal:  Nat Immunol       Date:  2021-08-30       Impact factor: 25.606

5.  CD5 Surface Expression Marks Intravascular Human Innate Lymphoid Cells That Have a Distinct Ontogeny and Migrate to the Lung.

Authors:  Arlisa Alisjahbana; Yu Gao; Natalie Sleiers; Elza Evren; Demi Brownlie; Andreas von Kries; Carl Jorns; Nicole Marquardt; Jakob Michaëlsson; Tim Willinger
Journal:  Front Immunol       Date:  2021-11-18       Impact factor: 7.561

6.  Altered Frequencies and Functions of Innate Lymphoid Cells in Melanoma Patients Are Modulated by Immune Checkpoints Inhibitors.

Authors:  Costanza Maria Cristiani; Mariaelena Capone; Cinzia Garofalo; Gabriele Madonna; Domenico Mallardo; Marilena Tuffanelli; Vito Vanella; Marta Greco; Daniela Patrizia Foti; Giuseppe Viglietto; Paolo Antonio Ascierto; Hergen Spits; Ennio Carbone
Journal:  Front Immunol       Date:  2022-01-31       Impact factor: 7.561

Review 7.  Innate Lymphoid Cells and Intestinal Inflammatory Disorders.

Authors:  Mingzhu Zheng; Jinfang Zhu
Journal:  Int J Mol Sci       Date:  2022-02-06       Impact factor: 5.923

Review 8.  Chimeric antigen receptor- and natural killer cell receptor-engineered innate killer cells in cancer immunotherapy.

Authors:  Cai Zhang; Yuan Hu; Weihua Xiao; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2021-07-15       Impact factor: 22.096

Review 9.  Human NK Cells in Autologous Hematopoietic Stem Cell Transplantation for Cancer Treatment.

Authors:  Ane Orrantia; Iñigo Terrén; Gabirel Astarloa-Pando; Olatz Zenarruzabeitia; Francisco Borrego
Journal:  Cancers (Basel)       Date:  2021-03-30       Impact factor: 6.639

Review 10.  Ikaros Proteins in Tumor: Current Perspectives and New Developments.

Authors:  Ruolan Xia; Yuan Cheng; Xuejiao Han; Yuquan Wei; Xiawei Wei
Journal:  Front Mol Biosci       Date:  2021-12-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.